TNFSF13B and scleroderma: We have not been able to show restored capacity of B cells to produce IL-10 by addition of 500 ng/mL BAFF-Fc-Chimera opposed to previous research performed in scleroderma [30], where BAFF inhibition restored B-eff/B-reg imbalances in mice.